Susquehanna International Group’s ClearPoint Neuro CLPT Stock Holding History

Susquehanna International Group’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Buy	124,300 +33,600	+37%	+$424K	﹤0.01%	7559
2025 Q4	$1.24M	Buy	90,700 +31,500	+53%	+$584K	﹤0.01%	6679
2025 Q3	$1.29M	Buy	59,200 +48,400	+448%	+$570K	﹤0.01%	6728
2025 Q2	$129K	Buy	+10,800	New	+$136K	﹤0.01%	11615
2025 Q1	–	Sell	-11,600	Closed	-$178K	–	12575
2024 Q4	$178K	Sell	11,600 -19,000	-62%	-$246K	﹤0.01%	10848
2024 Q3	$343K	Buy	30,600 +11,200	+58%	+$107K	﹤0.01%	9309
2024 Q2	$105K	Sell	19,400 -6,600	-25%	-$38.2K	﹤0.01%	11001
2024 Q1	$177K	Buy	+26,000	New	+$182K	﹤0.01%	10734
2022 Q4	–	Sell	-29,600	Closed	-$307K	–	12535
2022 Q3	$307K	Buy	+29,600	New	+$390K	﹤0.01%	9737
2022 Q2	–	Sell	-16,600	Closed	-$173K	–	12989
2022 Q1	$173K	Buy	16,600 +3,900	+31%	+$35.5K	﹤0.01%	11411
2021 Q4	$142K	Sell	12,700 -34,300	-73%	-$513K	﹤0.01%	11852
2021 Q3	$834K	Buy	47,000 +5,600	+14%	+$105K	﹤0.01%	8025
2021 Q2	$790K	Buy	+41,400	New	+$800K	﹤0.01%	8410

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Susquehanna International Group's CLPT Position: Q1 2026 in Review

Susquehanna International Group reduced its ClearPoint Neuro (CLPT) stake by 9.5% in Q1 2026, selling an estimated $180K and leaving 136,284 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #7336.

Susquehanna International Group first reported a position in CLPT in Q1 2021 and has held it in 18 quarters since. The position peaked at $7.83M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Susquehanna International Group held 136,284 shares of ClearPoint Neuro worth $1.24M as of Q1 2026.
Susquehanna International Group sold 14,272 ClearPoint Neuro shares in Q1 2026, an estimated $180K.
ClearPoint Neuro made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7336 holding.
Susquehanna International Group first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 18 quarters since.
Susquehanna International Group's ClearPoint Neuro position peaked at $7.83M in Q4 2024.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.